Prevalence of symptoms of anxiety and depression in patients with inflammatory bowel disease: a systematic review and meta-analysis

The Lancet Gastroenterology & Hepatology

Fecha de publicación: 12 de marzo de 2021

DOI: https://doi.org/10.1016/S2468-1253(21)00014-5

Autores: Brigida Barberio, MD ^†, Mohammad Zamani, MD ^†,Christopher J Black, MBBS, Prof Edoardo V Savarino, PhD, Prof Alexander C Ford, MD 

Background: Inflammatory bowel disease (IBD) is a lifelong condition with no cure. Patients with IBD might experience symptoms of common mental disorders such as anxiety and depression because of bidirectional communication via the gut–brain axis and chronicity of symptoms, and because of impaired quality of life and reduced social functioning. However, uncertainties remain about the magnitude of this problem. We aimed to assess prevalence of symptoms of anxiety or depression in adult patients with IBD.